| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | 1.688 | 9.097 | 26.426 | 24.743 | 27.048 | 26.458 | 29.528 | 19.748 |
| Total Income - EUR | - | - | 1.688 | 9.097 | 26.427 | 24.743 | 27.048 | 26.965 | 29.528 | 19.748 |
| Total Expenses - EUR | - | - | 1.656 | 8.650 | 15.135 | 12.617 | 9.466 | 13.820 | 17.198 | 17.673 |
| Gross Profit/Loss - EUR | - | - | 32 | 447 | 11.292 | 12.127 | 17.582 | 13.144 | 12.330 | 2.075 |
| Net Profit/Loss - EUR | - | - | 15 | 174 | 11.028 | 11.566 | 17.024 | 12.930 | 12.079 | 1.907 |
| Employees | - | - | 1 | 0 | 1 | 1 | 1 | 1 | 1 | 1 |
Check the financial reports for the company - Drgmad Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | 4.257 | 2.746 | 2.693 | 0 | 2.538 | 2.047 | 980 | 235 |
| Current Assets | - | - | 405 | 13 | 9.051 | 11.938 | 26.219 | 28.638 | 41.516 | 44.360 |
| Inventories | - | - | 0 | 0 | 4 | 299 | 579 | 0 | 0 | 0 |
| Receivables | - | - | 0 | 0 | 0 | 0 | 0 | 6 | 75 | 58 |
| Cash | - | - | 405 | 13 | 9.048 | 11.639 | 25.639 | 28.633 | 41.440 | 44.302 |
| Shareholders Funds | - | - | 59 | 232 | 11.254 | 11.773 | 28.535 | 30.209 | 42.197 | 43.868 |
| Social Capital | - | - | 44 | 43 | 211 | 207 | 202 | 203 | 202 | 201 |
| Debts | - | - | 4.603 | 2.527 | 490 | 165 | 222 | 476 | 299 | 727 |
| Income in Advance | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4932 - 4932" | |||||||||
| CAEN Financial Year |
4932
|
|||||||||
Comments - Drgmad Srl